JAN-2017 : Compelling data presented at the 27th edition of JESFC, Paris, January 13, 2017.
Journées Européennes de la Société Française de Cardiologie 2017 (JESFC-2017)
Les anticoagulants oraux directs : des preuves d’aujourd’hui aux attentes de demain
Clearly it is in no one’s interests for a clinical trial to fail. Whenever these high-stake activites are abandoned and drug development pathways are aborted, missed opportunities abound. Beyond the sponsor’s missed commercial opportunity, there are missed opportunities to advance
In a clinical trial, every piece of data contributes to the overall story being told. No matter how small or seemingly insignificant, all the information that emerges over the course of the process adds rich detail to the narrative. Two